Universidade de Brasília, Núcleo de Medicina Tropical, Programa de Pós-Graduação em Medicina Tropical, Brasília, DF, Brazil.
Universidade de Brasília, Núcleo de Medicina Tropical, Zika, Arbovirus and other Infections Cohort Studies (ZARICS), Brasília, DF, Brazil.
Braz J Infect Dis. 2024 Mar-Apr;28(2):103744. doi: 10.1016/j.bjid.2024.103744. Epub 2024 Apr 24.
This is a cost analysis study based on hospital admissions, conducted from the perspective of the Brazilian Unified Health System (SUS), carried out in a cohort of patients hospitalized at the University Hospital of Brasília (UHB) due to Severe Acute Respiratory Infections (SARI) caused by COVID-19, from April 1, 2020, to March 31, 2022. An approach based on macro-costing was used, considering the costs per patient identified in the Hospital Admission Authorizations (HAA). Were identified 1,015 HAA from 622 patients. The total cost of hospitalizations was R$ 2,875,867.18 for 2020 and 2021. Of this total, 86.41 % referred to hospital services and 13.59 % to professional services. The highest median cost per patient identified was for May 2020 (R$ 19,677.81 IQR [3,334.81-33,041.43]), while the lowest was in January 2021 (R$ 1,698.50 IQR [1,602.70-2,224.11]). The high cost of treating patients with COVID-19 resulted in a high economic burden of SARI due to COVID-19 for UHB and, consequently, for SUS.
这是一项基于住院的成本分析研究，从巴西统一卫生系统（SUS）的角度出发，对 2020 年 4 月 1 日至 2022 年 3 月 31 日期间因 COVID-19 导致的严重急性呼吸道感染（SARI）而住院于巴西利亚大学医院（UHB）的患者队列进行了研究。采用基于宏观成本核算的方法，考虑了住院授权书（HAA）中确定的每位患者的成本。从 622 名患者中确定了 1015 份 HAA。2020 年和 2021 年的住院总费用为 2875867.18 雷亚尔。其中，86.41%为医院服务，13.59%为专业服务。每个患者的中位数成本最高的是 2020 年 5 月（R$19677.81 IQR [3334.81-33041.43]），而最低的是 2021 年 1 月（R$1698.50 IQR [1602.70-2224.11]）。治疗 COVID-19 患者的高成本导致 UHB 以及因此 SUS 因 COVID-19 导致的 SARI 经济负担沉重。
